Michael Petusky

Stock Analyst at Barrington Research

(2.08)
# 3,022
Out of 5,008 analysts
204
Total ratings
35.56%
Success rate
-3.94%
Average return

Stocks Rated by Michael Petusky

Merit Medical Systems
Oct 7, 2025
Maintains: Outperform
Price Target: $103
Current: $82.70
Upside: +24.55%
Orthofix Medical
Sep 23, 2025
Maintains: Outperform
Price Target: $17
Current: $14.20
Upside: +19.72%
Option Care Health
Sep 23, 2025
Maintains: Outperform
Price Target: $38
Current: $27.11
Upside: +40.17%
LeMaitre Vascular
Sep 23, 2025
Maintains: Outperform
Price Target: $95
Current: $86.79
Upside: +9.46%
Henry Schein
Sep 23, 2025
Maintains: Outperform
Price Target: $78
Current: $64.88
Upside: +20.22%
Haemonetics
Sep 23, 2025
Maintains: Outperform
Price Target: $86
Current: $49.26
Upside: +74.58%
Anika Therapeutics
Sep 23, 2025
Maintains: Outperform
Price Target: $15
Current: $9.10
Upside: +64.84%
VerifyMe
Aug 14, 2025
Maintains: Outperform
Price Target: $1.25$1.5
Current: $1.10
Upside: +36.36%
Surmodics
Aug 11, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $28.82
Upside: -
DENTSPLY SIRONA
Aug 8, 2025
Maintains: Outperform
Price Target: $21$18
Current: $12.33
Upside: +45.99%
Maintains: Outperform
Price Target: $98$103
Current: $89.77
Upside: +14.74%
Maintains: Outperform
Price Target: $2.25
Current: $1.54
Upside: +46.10%
Downgrades: Market Perform
Price Target: n/a
Current: $6.75
Upside: -